Mast Therapeutics Competitors and Similar CompaniesClear all
Mast Therapeutics's competitors and similar companies include Zogenix, Durect, Tricida and Biofrontera.
 Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Biofrontera Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics. | |||
Founding Date | Founding Date 1995 | Founding Date 2006 | Founding Date N/A | Founding Date 2013 | Founding Date 2012 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Emeryville, US HQ Maidenhead, GB | Locations Cupertino, US HQ | Locations South San Francisco, US HQ | Locations Leverkusen, DE HQ |
Employees | Employees 3918% increase | Employees 743% increase | Employees 902% increase | Employees 11914% increase | Employees 91 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 45.3 m | Valuation ($) N/A | Valuation ($) 1.1 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) €13.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $4.8m (FY, 2021) | Cost of goods $78k (FY, 2024) | Cost of goods N/A | Cost of goods €2.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $2m (FY, 2024) | Gross profit N/A | Gross profit €11.2m (FY, 2025) |
Net income | Net income ($43m) (FY, 2021) | Net income ($227.4m) (FY, 2021) | Net income ($8.3m) (FY, 2024) | Net income ($176.6m) (FY, 2021) | Net income (€6.9m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 20m | Total funding raised $ 157m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Zogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyDurect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View company
Tricida
HQ
South San Francisco, US
Employees
119↑ 14% increase
Tricida operates in the healthcare industry focusing on pharmaceutical business.
View companyBiofrontera
HQ
Leverkusen, DE
Employees
91
Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
View company